Oesophageal cancer, Pancreatic cancer, Secondary cancers, Stomach cancer
Open
Phase 1/2
This study is looking at a drug called AZD5863 for cancer that has spread or cannot be treated with surgery or radiotherapy.
People may be able to take part if they have one of the following:
stomach cancer
cancer of the food pipe (oesophageal cancer)
cancer where the food pipe joins the stomach (gastro oesophageal junction cancer)
cancer of the pancreas
Recruitment start: 1 September 2024
Recruitment end: 15 October 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Lizzy Smyth
AstraZeneca
Last reviewed: 25 Feb 2026
CRUK internal database number: 19943